Tokyo, Japan

Hiroshi Tomoda


 

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • Minato-ku, JP (2003)
  • Tokyo, JP (1998 - 2013)
  • Chofu, JP (2009 - 2013)
  • Tokyo-to, JP (2009 - 2014)
  • Sagamihara, JP (2015 - 2018)
  • Kanagawa, JP (2022)

Company Filing History:


Years Active: 1998-2022

Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: Hiroshi Tomoda: Innovator in Therapeutic Compounds

Introduction: Hiroshi Tomoda, based in Tokyo, Japan, is a distinguished inventor and researcher with a remarkable portfolio of 25 patents. His work primarily focuses on developing novel therapeutic compounds aimed at combating complex infections and cholesterol-related conditions.

Latest Patents: Among his latest innovations are two significant patents. The first patent involves a compound exhibiting therapeutic activity against Mycobacterium avium complex (MAC) infection. This invention offers a unique antibacterial agent structurally different from existing MAC treatments. The compound, defined by a specific formula, provides an important advancement in the field of infectious disease treatment. The second notable patent addresses the development of a non-natural pharmaceutical compound that selectively inhibits cholesterol acyltransferase isozyme 2 (ACAT2). This compound operates through a different mechanism than traditional statin medications, presenting a promising alternative for patients.

Career Highlights: Hiroshi Tomoda has made substantial contributions to pharmaceutical sciences throughout his career. His expertise and innovative approaches have been instrumental in the development of therapies for serious medical conditions. He has significantly advanced the understanding of complex infections and cholesterol management through his inventive efforts.

Collaborations: Throughout his career, Hiroshi Tomoda has collaborated with esteemed professionals, including notable researchers Satoshi Omura and Rokuro Masuma. These collaborations have further enhanced the impact and scope of his research, leading to groundbreaking advancements in therapeutics.

Conclusion: Hiroshi Tomoda exemplifies the passion and ingenuity of modern inventors in the pharmaceutical field. With an impressive array of patents and a commitment to improving health outcomes, he continues to be a key player in the development of novel therapeutic agents. His contributions not only reflect his expertise but also the potential for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…